<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812439670</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812439670</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Otology and Neurotology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Screening of <italic>SLC26A4, FOXI1, KCNJ10</italic>, and <italic>GJB2</italic> in Bilateral Deafness Patients with Inner Ear Malformation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Kaitian</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599812439670">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Xianren</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599812439670">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sun</surname><given-names>Liang</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-0194599812439670">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jiang</surname><given-names>Hongyan</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599812439670">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599812439670"><label>1</label>Department of Otorhinolaryngology, the First Affiliated Hospital, Sun Yat-Sen University and Institute of Otorhinolaryngology, Sun Yat-sen University, Guangzhou, PR China</aff>
<author-notes>
<corresp id="corresp1-0194599812439670">Hongyan Jiang, MD, PhD, Otorhinolaryngology, Zhongshan Second Road, Guangzhou, 510080, China Email: <email>hyjiangus@163.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>146</volume>
<issue>6</issue>
<fpage>972</fpage>
<lpage>978</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>9</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>1</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>1</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<p><italic>Objective</italic>. Bilateral nonsyndromic sensorineural hearing loss associated with inner ear malformation is closely related to genetics. <italic>SLC26A4</italic> is considered to be the major involved gene. Recently, <italic>FOXI1</italic> and <italic>KCNJ10</italic> mutations have been linked to enlarged vestibular aqueducts and <italic>GJB2</italic> mutations linked to temporal bone malformation. The authors aimed to investigate the mutation spectrums of these genes in Chinese patients with bilateral hearing impairment associated with inner ear malformation.</p>
<p><italic>Study Design</italic>. Cross-sectional study.</p>
<p><italic>Setting</italic>. Affiliated hospital of the university.</p>
<p><italic>Subjects and Methods</italic>. The authors analyzed the <italic>GJB2, SLC26A4, FOXI1</italic>, and <italic>KCNJ10</italic> gene sequences in 43 patients presenting with bilateral hearing impairment associated with inner ear malformation using pyrosequencing and direct DNA sequencing.</p>
<p><italic>Results</italic>. In total, 74.4% (32/43) of patients carried at least 1 of 14 pathogenic <italic>SLC26A4</italic> mutations, including 6 novel mutations and 4 polymorphisms. Patients with enlarged vestibular aqueducts had a higher rate of <italic>SLC26A4</italic> mutation than Mondini dysplasia patients. No <italic>FOXI1</italic> or <italic>KCNJ10</italic> potential pathogenic mutation was present, and <italic>GJB2</italic> biallelic pathogenic mutations were uncommon (2.3%; 1/43). No significant correlation was observed between the genotype and phenotype of <italic>SLC26A4</italic> mutations.</p>
<p><italic>Conclusion. SLC26A4</italic> accounts for 74.4% of inner ear malformations in our cohort, whereas <italic>FOXI1, KCNJ10</italic>, and <italic>GJB2</italic> mutations are not common. Other possible genes or external factors may contribute to this multibranch abnormality.</p>
</abstract>
<kwd-group>
<kwd><italic>FOXI1</italic></kwd>
<kwd><italic>GJB2</italic></kwd>
<kwd>inner ear malformation</kwd>
<kwd><italic>KCNJ10</italic></kwd>
<kwd>nonsyndromic sensorineural hearing loss</kwd>
<kwd><italic>SLC26A4</italic></kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Inner ear malformations such as enlarged vestibular aqueduct (EVA) and Mondini dysplasia are considered important pathologic changes that contribute to congenital hearing impairment. <italic>SLC26A4</italic> is the major gene linked to EVA and Mondini dysplasia.<sup><xref ref-type="bibr" rid="bibr1-0194599812439670">1</xref>,<xref ref-type="bibr" rid="bibr2-0194599812439670">2</xref></sup> The <italic>SLC26A4</italic> gene has 21 exons, contains an open reading frame of 2343 base pairs, and has an extensive mutation map covering all exons and their flanking sequences. It is speculated that mutations in <italic>SLC26A4</italic> induce EVA through influencing ionic fluid homeostasis in the inner ear.<sup><xref ref-type="bibr" rid="bibr3-0194599812439670">3</xref></sup> Although homozygous mutations are common, compound heterozygous mutations, previously considered to be pathogenic mutations responsible for EVA, represent a large part of the <italic>SLC26A4</italic> mutation spectrum.<sup><xref ref-type="bibr" rid="bibr4-0194599812439670">4</xref>,<xref ref-type="bibr" rid="bibr5-0194599812439670">5</xref></sup> The pathogenic mechanism of <italic>SLC26A4</italic> compound heterozygous mutations is not fully understood, as functional analyses have not been completed.<sup><xref ref-type="bibr" rid="bibr6-0194599812439670">6</xref></sup> To date, more than 200 <italic>SLC26A4</italic> mutations have been reported in different ethnic groups (indexed at <ext-link ext-link-type="uri" xlink:href="http://www.healthcare.uiowa.edu/labs/pendredandbor/slcMutations.htm">www.healthcare.uiowa.edu/labs/pendredandbor/slcMutations.htm</ext-link>). IVS7-2A&gt;G and c.2168A&gt;G are the 2 most frequent mutations in Chinese patients<sup><xref ref-type="bibr" rid="bibr7-0194599812439670">7</xref><xref ref-type="bibr" rid="bibr8-0194599812439670"/>-<xref ref-type="bibr" rid="bibr9-0194599812439670">9</xref></sup>; however, <italic>SLC26A4</italic> mutations are present in only 24% to 97.9% of patients depending on the ethnic origins of the population tested,<sup><xref ref-type="bibr" rid="bibr10-0194599812439670">10</xref><xref ref-type="bibr" rid="bibr11-0194599812439670"/><xref ref-type="bibr" rid="bibr12-0194599812439670"/>-<xref ref-type="bibr" rid="bibr13-0194599812439670">13</xref></sup> implying that inner ear malformation is a multibranched disease.</p>
<p>
<italic>FOXI1</italic>, the <italic>SLC26A4</italic> transcriptional regulation factor, has been implicated in the development of inner ear abnormalities.<sup><xref ref-type="bibr" rid="bibr13-0194599812439670">13</xref>,<xref ref-type="bibr" rid="bibr14-0194599812439670">14</xref></sup> <italic>FOXI1</italic> mutations can lead to malformations raging from EVA to common cavity of the cochlea and vestibule in vivo.<sup><xref ref-type="bibr" rid="bibr15-0194599812439670">15</xref></sup> A <italic>FOXI1</italic> mutation was first observed in a nonsyndromic patient with EVA carrying a double heterozygous <italic>SLC26A4/FOXI1</italic> mutation.<sup><xref ref-type="bibr" rid="bibr13-0194599812439670">13</xref></sup> Similarly, the <italic>SLC26A4</italic> functional partner <italic>KCNJ10</italic> has been also implicated in nonsyndromic patients with EVA, with double heterozygous <italic>SLC26A4/KCNJ10</italic> mutations reported in 2 individuals.<sup><xref ref-type="bibr" rid="bibr14-0194599812439670">14</xref></sup> Thus, <italic>FOXI1</italic> and <italic>KCNJ10</italic> may contribute to deafness and associated inner ear abnormalities. The <italic>FOXI1</italic> gene was examined in Chinese patients, and no pathogenic mutation was found.<sup><xref ref-type="bibr" rid="bibr16-0194599812439670">16</xref></sup> <italic>KCNJ10</italic> has not been reported in Chinese patients yet.</p>
<p>The exact interaction between <italic>GJB2</italic> and temporal bone malformation remain unclear. Propst et al<sup><xref ref-type="bibr" rid="bibr17-0194599812439670">17</xref></sup> reported that temporal bone anomalies, including EVA, are common in <italic>GJB2</italic>-related hearing loss, whereas Kenna et al<sup><xref ref-type="bibr" rid="bibr18-0194599812439670">18</xref></sup> found that only 10% of biallelic <italic>GJB2</italic> patients had abnormalities, mostly subtle, and none had EVA. Lee et al<sup><xref ref-type="bibr" rid="bibr19-0194599812439670">19</xref></sup> reported that patients who are wild type for <italic>GJB2</italic> were more likely to have EVA than those with biallelic and heterozygous <italic>GJB2</italic> mutations and concluded that temporal bone anomalies were uncommon in patients with <italic>GJB2</italic> mutations.</p>
<p>The distribution and frequency of <italic>SLC26A4, FOXI1, KCNJ10</italic>, and <italic>GJB2</italic> gene mutations in Chinese patients with inner ear malformations and bilateral hearing loss are not known. We selected patients with congenital bilateral hearing loss using the inner ear malformation classification of Sennaroglu and Saatci<sup><xref ref-type="bibr" rid="bibr20-0194599812439670">20</xref></sup> and investigated the mutation spectrum of <italic>SLC26A4, FOXI1, KCNJ10</italic>, and <italic>GJB2</italic> in Chinese patients with bilateral hearing impairment associated with inner ear malformation in our outpatient department.</p>
<sec id="section1-0194599812439670" sec-type="methods">
<title>Patients and Methods</title>
<sec id="section2-0194599812439670">
<title>Patients</title>
<p>Our cohort consisted of 43 sporadic or familial subjects mainly from southern China who attended our outpatient department between July 2010 and May 2011. The eligibility criterion was an inner ear malformation imaged by computed tomography (CT) or magnetic resonance imaging (MRI) associated with bilateral nonsyndromic sensorineural hearing loss. Inner ear malformations were defined using the classification of Sennaroglu and Saatci.<sup><xref ref-type="bibr" rid="bibr20-0194599812439670">20</xref></sup> The study was approved by the institutional review board of the First Affiliated Hospital, Sun Yat-sen University. Informed consent was obtained from all patients or their parents.</p>
</sec>
<sec id="section3-0194599812439670">
<title>Clinical Evaluation</title>
<p>Each patient was evaluated with a complete medical history and physical examination to exclude the possibility of environmental causes. All patients underwent an otoscopic examination of the ear, nose, and throat and a general examination, with systematic assessment for signs of syndromic forms of deafness, in particular, goiter and hypothyroidism. Deaf patients underwent pure-tone audiometry or auditory brainstem response (ABR) and auditory steady-state response (ASSR). Air-conduction pure-tone average (ACPTA) thresholds in the conversational frequencies (0.5, 1, 2, and 4 kHz) were calculated and used to define the severity of deafness as mild (26-40 dB), moderate (41-70 dB), severe (70-90 dB), profound (90-119 dB), or anacusis (&gt;120 dB). The severity of deafness was defined by the degree of hearing loss in the better ear. Hearing loss was considered progressive if the patient lost more than 8 dB in the ACPTA thresholds at conversational frequencies in 2 reliable audiometric tests carried out at least 5 years apart. Fluctuant deafness was defined when the mean hearing level at conversational frequencies increased by more than 10 dB between 2 successive audiograms.<sup><xref ref-type="bibr" rid="bibr11-0194599812439670">11</xref></sup>
</p>
</sec>
<sec id="section4-0194599812439670">
<title>Molecular Analyses</title>
<p>Blood samples were collected from the subjects and DNA isolation was performed using a standard chloroform extraction method. Briefly, white blood cells were consecutively dissolved by sodium dodecyl sulfate (SDS) and protease K. Genomic DNA were then separated and purified by absolute ethanol after protein denaturalization by chloroform. The mean DNA A260/A280 ratio was 1.8 to 2.0. A molecular screening scheme was designed (<xref ref-type="fig" rid="fig1-0194599812439670"><bold>Figure 1</bold></xref>). First, exon 2 of <italic>GJB2</italic> was screened in all patients using direct sequencing as previously described.<sup><xref ref-type="bibr" rid="bibr21-0194599812439670">21</xref></sup> Pyrosequencing was used to screen for the 2 common <italic>SLC26A4</italic> gene mutations, IVS7-2A&gt;G and c.2168A&gt;G (detailed procedures have been previously described elsewhere<sup><xref ref-type="bibr" rid="bibr22-0194599812439670">22</xref></sup> and in <xref ref-type="table" rid="table1-0194599812439670"><bold>Table 1</bold></xref>). <italic>SLC26A4</italic>,<sup><xref ref-type="bibr" rid="bibr23-0194599812439670">23</xref></sup> <italic>FOXI1</italic>,<sup><xref ref-type="bibr" rid="bibr13-0194599812439670">13</xref></sup> and <italic>KCNJ10</italic>
<sup><xref ref-type="bibr" rid="bibr14-0194599812439670">14</xref></sup> were subsequently amplified by polymerase chain reaction (PCR) and directly sequenced using an ABI 3730 Genetic Sequencer (Applied Biosystems, Foster City, California), and all sequences were aligned and compared with the published sequences from the NCBI (<italic>GJB2</italic>: NG_008358.1; <italic>SLC26A4</italic>: NG_008489.1; <italic>FOXI1</italic>: NG_012068.1; <italic>KCNJ10</italic>: NG_016411.1).</p>
<fig id="fig1-0194599812439670" position="float">
<label>Figure 1.</label>
<caption>
<p>Diagram of the molecular screening scheme used for all patients.</p>
</caption>
<graphic xlink:href="10.1177_0194599812439670-fig1.tif"/>
</fig>
<table-wrap id="table1-0194599812439670" position="float">
<label>Table 1.</label>
<caption>
<p>PCR Primers for <italic>SLC26A4</italic> Pyrosequencing</p>
</caption>
<graphic alternate-form-of="table1-0194599812439670" xlink:href="10.1177_0194599812439670-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Locus</th>
<th align="center">Primer</th>
</tr>
</thead>
<tbody>
<tr>
<td>IVS7-2A&gt;G F</td>
<td>Biotin-GGCAGTTAAGGAATTAAATGATCG</td>
</tr>
<tr>
<td>IVS7-2A&gt;G R</td>
<td>CTCCATATGAAATGGCAGTAGCAA</td>
</tr>
<tr>
<td>IVS7-2A&gt;G S</td>
<td>GGCAGTAGCAATTATCG</td>
</tr>
<tr>
<td>c.2168A&gt;G F</td>
<td>GCGGGTTCTTTGACGACAA</td>
</tr>
<tr>
<td>c.2168A&gt;G R</td>
<td>Biotin-CCTTGACCCTCTTGAGATTTCAC</td>
</tr>
<tr>
<td>c.2168A&gt;G S</td>
<td>CACATTCTTTTTGACGG</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section5-0194599812439670">
<title>Statistical Analysis</title>
<p>Patient age, hearing loss onset, and hearing levels were reported as mean ± standard deviation values. The independent sample <italic>t</italic> test was used to compare hearing levels using SPSS 13.0 (SPSS, Inc, an IBM Company, Chicago, Illinois), and differences were considered significant if the <italic>P</italic> values were less than .05.</p>
</sec>
</sec>
<sec id="section6-0194599812439670" sec-type="results">
<title>Results</title>
<p>We recruited 43 patients (24 males and 19 females) from 3 multiplex and 37 simplex families, mainly from southern China. Patients were aged 1.3 to 37 years (7.02 ± 7.00 years). Their inner ear malformations included 34 EVA, 6 incomplete partition type II (IP-II, Mondini dysplasia), 1 incomplete partition type I (IP-I), 1 cochlear aplasia plus IP-II, and 1 cochlear hypoplasia. The onset of hearing loss ranged from birth to 72 months (17.3 ± 14.1 months). Head injury was the most common predisposing factor. Hearing evolution depended on the severity or type of inner ear malformation or external factors. Hearing levels varied from moderate to anacusis. No goiter was found within the cohort. All 43 patients were treated with cochlear implantation (23) or hearing aid (19) except 1 child, who was untreated.</p>
<p>Four types of <italic>GJB2</italic> mutations, including 1 heterozygous c.109G&gt;A mutation, 2 c.79G&gt;A and c.341A&gt;G polymorphisms, and a single heterogenic <italic>GJB2</italic> homozygous c.109G&gt;A mutation with a <italic>SLC26A4</italic> compound heterozygous mutation (patient 10, <xref ref-type="fig" rid="fig2-0194599812439670"><bold>Figure 2</bold></xref>), were detected. No direct correlation was observed between <italic>GJB2</italic> mutations and inner ear malformations. <italic>GJB2</italic> biallelic pathogenic mutations were uncommon (2.3%; 1/43).</p>
<fig id="fig2-0194599812439670" position="float">
<label>Figure 2.</label>
<caption>
<p>Heterogenic mutations of <italic>GJB2</italic> and <italic>SLC26A4</italic> in patient 10 with an enlarged vestibular aqueduct. Genetic sequencing revealed a <italic>GJB2</italic> homozygous 109G&gt;A mutation and <italic>SLC26A4</italic> compound heterozygous IVS7-2A&gt;G and 2000T&gt;C mutations.</p>
</caption>
<graphic xlink:href="10.1177_0194599812439670-fig2.tif"/>
</fig>
<p>Using pyrosequencing, we detected bilateral <italic>SLC26A4</italic> IVS7-2A&gt;G and c.2168A&gt;G mutations in 11 patients, which were confirmed by direct DNA sequencing (<xref ref-type="fig" rid="fig3-0194599812439670"><bold>Figure 3</bold></xref>).</p>
<fig id="fig3-0194599812439670" position="float">
<label>Figure 3.</label>
<caption>
<p>Pyrosequencing and DNA sequencing validation of SLC26A4 IVS7-2A&gt;G homozygous mutation in patient 1 with enlarged vestibular aqueduct (A-C) and bilateral hearing loss detected by ABR (D). Pyrosequencing revealed an antisense homozygous IVS7-2T&gt;C mutation (E), correlating with DNA sequencing (F).</p>
</caption>
<graphic xlink:href="10.1177_0194599812439670-fig3.tif"/>
</fig>
<p>In the remainder of the patients (n = 32), the entire <italic>SLC26A4</italic> coding sequence was subjected to DNA sequencing; another 17 patients were confirmed as carrying 2 pathologic mutations, and 4 patients carried a single pathologic mutation. In total, we found 4 <italic>SLC26A4</italic> polymorphisms (IVS10+27C&gt;A, IVS11+47T&gt;C, IVS19-24T&gt;A, IVS17-74G&gt;A) and 14 <italic>SLC26A4</italic> probable pathogenic mutations, including 8 known mutations (IVS7-A&gt;G, IVS14-2A&gt;G,<sup><xref ref-type="bibr" rid="bibr24-0194599812439670">24</xref></sup> c.1079C&gt;T, c.1343C&gt;T, c.754T&gt;C, c.259G&gt;T, c.2168A&gt;G, and c.1229C&gt;T) and 6 novel compound heterozygous mutations (c.2086C&gt;T, c.2000T&gt;C, c.413T&gt;A, c.1691insA, c.1919G&gt;A, and IVS13-1insC). There were 11 homozygous mutations (9 IVS7-2A&gt;G, 1 c.2168A&gt;G, 1 c.754T&gt;C) and 17 compound heterozygous mutations. Among the 60 pathogenic alleles, including 28 patients with bialleles and 4 patients with a monoallele, IVS7-2A&gt;G was the most common mutation, accounting for 58.3% (35/60; <xref ref-type="table" rid="table2-0194599812439670"><bold>Table 2</bold></xref>). Patients with EVA had a higher <italic>SLC26A4</italic> mutation rate (85.3%; 29/34) than patients with IP-II (42.9%; 3/7), and taken together, 78.0% (32/41) of patients with EVA and IP-II carried a <italic>SLC26A4</italic> mutation (<xref ref-type="table" rid="table3-0194599812439670"><bold>Table 3</bold></xref>).</p>
<table-wrap id="table2-0194599812439670" position="float">
<label>Table 2.</label>
<caption>
<p>
<italic>SLC26A4</italic> Mutation Spectrums in Our Cohort of Chinese Patients with Inner Ear Malformations Associated with Hearing Loss</p>
</caption>
<graphic alternate-form-of="table2-0194599812439670" xlink:href="10.1177_0194599812439670-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="("/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Genotype</th>
<th align="center">Allele Frequency, No. (%)</th>
<th align="center">AA Change</th>
<th align="center">Location</th>
<th align="center">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td>IVS7-2A&gt;G</td>
<td>35/60 (58.3)</td>
<td>Splice site</td>
<td>Intron 7</td>
<td>9</td>
</tr>
<tr>
<td>c.2168A&gt;G</td>
<td>4/60 (6.7)</td>
<td>p.H723R</td>
<td>Exon 19</td>
<td>10</td>
</tr>
<tr>
<td>c.754T&gt;C</td>
<td>4/60 (6.7)</td>
<td>p.S252P</td>
<td>Exon 6</td>
<td>23</td>
</tr>
<tr>
<td>c.1229C&gt;T</td>
<td>4/60 (6.7)</td>
<td>p.T410M</td>
<td>Exon 10</td>
<td>10</td>
</tr>
<tr>
<td>c.1079C&gt;T</td>
<td>3/60 (5.0)</td>
<td>p.A360V</td>
<td>Exon 9</td>
<td>16</td>
</tr>
<tr>
<td>c.1343C&gt;T</td>
<td>1/60 (1.7)</td>
<td>p.S448L</td>
<td>Exon 11</td>
<td>16</td>
</tr>
<tr>
<td>c.2086C&gt;T</td>
<td>2/60 (3.3)</td>
<td>p.Q696 Stop</td>
<td>Exon 18</td>
<td>Novel</td>
</tr>
<tr>
<td>c.2000T&gt;C</td>
<td>1/60 (1.7)</td>
<td>p.F667S</td>
<td>Exon 17</td>
<td>Novel</td>
</tr>
<tr>
<td>c.259G&gt;T</td>
<td>1/60 (1.7)</td>
<td>p.D87Y</td>
<td>Exon 3</td>
<td>27</td>
</tr>
<tr>
<td>c.413T&gt;A</td>
<td>1/60 (1.7)</td>
<td>p.V138D</td>
<td>Exon 4</td>
<td>Novel</td>
</tr>
<tr>
<td>c.1691 insA</td>
<td>1/60 (1.7)</td>
<td>Frameshift</td>
<td>Exon 15</td>
<td>Novel</td>
</tr>
<tr>
<td>c.1919G&gt;A</td>
<td>1/60 (1.7)</td>
<td>p.W640 Stop</td>
<td>Exon 17</td>
<td>Novel</td>
</tr>
<tr>
<td>IVS14-2A&gt;G</td>
<td>1/60 (1.7)</td>
<td>Splice site</td>
<td>Intron 14</td>
<td>24</td>
</tr>
<tr>
<td>IVS13-1 insC</td>
<td>1/60 (1.7)</td>
<td>Splice site</td>
<td>Intron 13</td>
<td>Novel</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599812439670">
<p>There were 60 pathogenic alleles, including 28 patients with bialleles and 4 patients with a monoallele.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0194599812439670" position="float">
<label>Table 3.</label>
<caption>
<p>Summary of <italic>SLC26A4</italic> Gene Mutations in Patients with Different Inner Ear Malformations</p>
</caption>
<graphic alternate-form-of="table3-0194599812439670" xlink:href="10.1177_0194599812439670-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="("/>
<col align="char" char="("/>
</colgroup>
<thead>
<tr>
<th align="left">Genotype Phenotype</th>
<th align="center">Biallele, No. (%)</th>
<th align="center">Monoallele, No. (%)</th>
<th align="center">Zero Allele, No. (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>EVA</td>
<td>26/34 (76.5)</td>
<td>3/34 (8.8)</td>
<td>5/34 (14.7)</td>
</tr>
<tr>
<td>IP-II</td>
<td>2/7 (28.6)</td>
<td>1/7 (14.3)</td>
<td>4/7 (57.1)</td>
</tr>
<tr>
<td>EVA + IP-II</td>
<td>28/41 (68.3)</td>
<td>4/41 (9.8)</td>
<td>9/41 (22.0)</td>
</tr>
<tr>
<td>IP-I</td>
<td>0</td>
<td>0</td>
<td>1/1 (100.0)</td>
</tr>
<tr>
<td>Cochlear aplasia</td>
<td>0</td>
<td>0</td>
<td>1/1 (100.0)<sup><xref ref-type="table-fn" rid="table-fn3-0194599812439670">a</xref></sup></td>
</tr>
<tr>
<td>Cochlear hypoplasia</td>
<td>0</td>
<td>0</td>
<td>1/1 (100.0)</td>
</tr>
<tr>
<td>All patients</td>
<td>28/43 (65.1)</td>
<td>4/43 (9.3)</td>
<td>11/43 (25.6)<sup><xref ref-type="table-fn" rid="table-fn3-0194599812439670">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0194599812439670">
<p>Abbreviations: EVA, enlarged vestibular aqueduct; IP-I, incomplete partition type I; IP-II, incomplete partition type II (Mondini deformity).</p>
</fn>
<fn id="table-fn3-0194599812439670">
<label>a</label>
<p>Patient 9 had separate IP-II and cochlear aplasia.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Furthermore, the 15 patients who were all sporadic with 1 or no <italic>SLC26A4</italic> mutation were screened for possible mutations in the <italic>FOXI1</italic> and <italic>KCNJ10</italic> coding sequences, and no pathogenic mutations were detected. <italic>FOXI1</italic> c.1044T&gt;C (p.Y348Y) was found in all 15 patients, and c.279G&gt;A (p.R93R) was present in 6 patients. Only 1 patient carried a novel <italic>KCNJ10</italic> c.1053C&gt;T (p.D351D) heterozygous mutation.</p>
<p>In our cohort, 93.0% of patients suffered from bilateral severe to profound sensorineural hearing loss, and 7.0% of patients had moderate hearing impairment (<xref ref-type="fig" rid="fig4-0194599812439670"><bold>Figure 4</bold></xref>). Flat and downgraded audiograms were most common. As pure-tone audiometry (PTA) and ASSR adopt different hearing indexes (hearing level [HL] and sound pressure level [SpL]), we analyzed these results separately. Among the 18 patients taking the PTA test, the 13 patients with biallelic mutations averaged 87.94 ± 9.10 dB HL compared with 89.9 ± 23.0 dB HL in the 4 patients without biallelic mutations. The results of the 25 patients who underwent ASSR examination were compared, with average hearing levels of 93.58 ± 22.2 dB SpL in the 15 patients with biallelic mutations and 104.65 ± 13.4 dB SpL in the 10 patients without biallelic mutations. No significant differences in hearing levels were observed in either the PTA or ASSR results (<italic>P</italic> &gt; .05; <xref ref-type="table" rid="table4-0194599812439670"><bold>Table 4</bold></xref>).</p>
<fig id="fig4-0194599812439670" position="float">
<label>Figure 4.</label>
<caption>
<p>Inner ear malformation <italic>SLC26A4</italic> genotype-phenotype analysis.</p>
</caption>
<graphic xlink:href="10.1177_0194599812439670-fig4.tif"/>
</fig>
<table-wrap id="table4-0194599812439670" position="float">
<label>Table 4.</label>
<caption>
<p>
<italic>SLC26A4</italic> Genotype and Hearing Levels Comparison</p>
</caption>
<graphic alternate-form-of="table4-0194599812439670" xlink:href="10.1177_0194599812439670-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="plusmn"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="center" colspan="3">Mono + Zero Allele</th>
<th/>
</tr>
<tr>
<th/>
<th align="center">Biallele</th>
<th align="center">Monoallele</th>
<th align="center">Zero Allele</th>
<th align="center">Total</th>
<th align="center"><italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>PTA (HL)</td>
<td>87.94 ± 9.10 (13)</td>
<td align="center">80 ± 0 (1)</td>
<td>92.38 ± 25.74 (4)</td>
<td>89.90 ± 22.97 (5)</td>
<td>.861</td>
</tr>
<tr>
<td>ASSR (SpL)</td>
<td>93.58 ± 22.20 (15)</td>
<td>101.08 ± 10.87 (3)</td>
<td>106.18 ± 14.92 (7)</td>
<td>104.65 ± 13.4 (10)</td>
<td>.173</td>
</tr>
<tr>
<td>PTA + ASSR</td>
<td>90.9 ± 17.34 (28)</td>
<td>95.72 ± 13.63 (4)</td>
<td>103.92 ± 13.60 (9)</td>
<td>99.73 ± 17.85 (15)</td>
<td>.125</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0194599812439670">
<p><italic>P</italic> values calculated from the data of “mean ± SD” in Biallele and Total in the same row using the Student <italic>t</italic> test. Abbreviations: ASSR, auditory steady-state response; HL, hearing level; PTA, pure-tone audiometry; SpL, sound pressure level.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section7-0194599812439670" sec-type="discussion">
<title>Discussion</title>
<p>Our research indicated that <italic>SLC26A4</italic> accounts for 74.4% (32/43) of inner ear malformations, with 78.0% (32/41) of patients with EVA and IP-II carrying at least 1 <italic>SLC26A4</italic> mutation. Patients with EVA have a higher <italic>SLC26A4</italic> mutation rate than patients with IP-II (85.3% vs 42.9%), implying that EVA is more likely to have a <italic>SLC26A4</italic> genetic origin. A total of 14 potential pathogenic <italic>SLC26A4</italic> mutations and 4 <italic>SLC26A4</italic> polymorphisms were detected. IVS7-2A&gt;G was most common, accounting for 58.3% of all pathologic mutations. We identified 6 novel <italic>SLC26A4</italic> mutations to provide evidence in favor of the wide <italic>SLC26A4</italic> mutation spectrum. These novel mutations, inherited separately from the probands’ parents with normal hearing, were all present in compound heterozygous states. This implies that alone, <italic>SLC26A4</italic> heterozygous mutations are not sufficient to cause deafness.</p>
<p>A role for <italic>FOXI1</italic> and <italic>KCNJ10</italic> in deafness associated with EVA has been suggested by previous studies,<sup><xref ref-type="bibr" rid="bibr13-0194599812439670">13</xref>,<xref ref-type="bibr" rid="bibr14-0194599812439670">14</xref></sup> but no pathogenic mutations were found in several subsequent studies.<sup><xref ref-type="bibr" rid="bibr25-0194599812439670">25</xref></sup> Our study did not find any potential pathogenic mutations in the <italic>FOXI1</italic> and <italic>KCNJ10</italic> genes. We found only 2 <italic>FOXI1</italic> mutations—c.279G&gt;A (p.R93R) and c.1044T&gt;C (p.Y348Y)—and 1 <italic>KCNJ10</italic> mutation, c.1053C&gt;T (p.D351D), which does not lead to an amino acid change. These results are not in favor of a digenism between <italic>SLC26A4</italic> and either <italic>FOXI1</italic> or <italic>KCNJ10</italic> in inner ear malformations. The <italic>FOXI1</italic> and <italic>KCNJ10</italic> genes may not be involved in our cohort because of the relatively small sample size; therefore, further large cohort studies are required to confirm the role of <italic>FOXI1</italic> and <italic>KCNJ10</italic> in inner ear malformations in Chinese patients.</p>
<p>The exact fundamental interaction of <italic>GJB2</italic> with temporal bone malformations, including inner ear malformation, remains controversial. In this research, we attempted to investigate the intrinsic relationship between <italic>GJB2</italic> and inner ear malformation. An intriguing heterogenic mutation was observed in patient 10 carrying <italic>GJB2</italic> homozygous c.109G&gt;A and <italic>SLC26A4</italic> compound heterozygous IVS7-2A&gt;G and c.2000T&gt;C mutations. <italic>GJB2</italic> homozygous c.109G&gt;A was previously considered to be a pathogenic mutation causing moderate to profound deafness.<sup><xref ref-type="bibr" rid="bibr26-0194599812439670">26</xref></sup> Both <italic>SLC26A4</italic> IVS7-2A&gt;G and c.2000T&gt;C are potential pathogenic mutations responsible for EVA; however, it is more likely to speculate that coincidental digenism occurs in this patient. We found other patients carrying <italic>GJB2</italic> polymorphisms or heterozygous pathogenic mutations, which favors a theory of uncommon <italic>GJB2</italic> biallelic pathogenic mutations in patients with inner ear malformations.</p>
<p>According to Hulander et al,<sup><xref ref-type="bibr" rid="bibr15-0194599812439670">15</xref></sup> inner ear malformations appear to lead to progressive degrees of changes in <italic>FOXI1</italic> mutant mice, indicating that <italic>FOXI1</italic> mutations may lead to different pathologic changes ranging from EVA to common cavity of the cochlea. Other genes, including <italic>SLC26A4, KCNJ10, FGF-3</italic>, and <italic>PAX2</italic>, participate in the functional control of normal inner ear development, indicating the genetic heterogeneity of inner ear malformation, prompting us to presume that other genes may be involved in the 25.6% (11/43) patients without <italic>SLC26A4, FOXI1, KCNJ10</italic>, or <italic>GJB2</italic> mutations in our cohort.</p>
<p>In addition, the absence of <italic>SLC26A4, FOXI1, KCNJ10</italic>, or <italic>GJB2</italic> mutations in patients with inner ear malformation could be explained by several factors. First, undetected <italic>SLC26A4, FOXI1</italic>, or <italic>KCNJ10</italic> mutations could be present in these patients within active cryptic splice sites, introns, or the promoter region. Second, the specific nongenetic causes of inner ear malformation have not been fully identified. For example, congenital cytomegalovirus infection is a common nongenetic cause of hearing loss in children but accounts for few, if any, cases of EVA.<sup><xref ref-type="bibr" rid="bibr27-0194599812439670">27</xref></sup> In addition, the action of an environmental teratogen that disrupts normal inner ear development cannot be completely ruled out.</p>
<p>In this study, we adopted a pyrosequencing methodology to screen 2 frequent <italic>SLC26A4</italic> mutations, IVS7-2A&gt;G and c.2168A&gt;G. Pyrosequencing has previously been used for screening procedures,<sup><xref ref-type="bibr" rid="bibr22-0194599812439670">22</xref></sup> and our results validate this approach. IVS7-2A&gt;G and c.2168A&gt;G contributed to 58.3% and 6.7% of all <italic>SLC26A4</italic> mutations, indicating that a preferred screening for these alleles can facilitate the routine molecular analysis of <italic>SLC26A4</italic> in Chinese patients. In fact, the IVS7-2A&gt;G mutation is common in Eastern Asia, as several large cohort investigations have reported a high prevalence of IVS7-2A&gt;G in the Chinese population (22.3%-64.6%).<sup><xref ref-type="bibr" rid="bibr7-0194599812439670">7</xref><xref ref-type="bibr" rid="bibr8-0194599812439670"/>-<xref ref-type="bibr" rid="bibr9-0194599812439670">9</xref>,<xref ref-type="bibr" rid="bibr28-0194599812439670">28</xref></sup> Haplotype and single-nucleotide polymorphism (SNP) analysis of IVS7-2A&gt;G suggested that the mutation may originate from a common ancestor in Taiwanese individuals.<sup><xref ref-type="bibr" rid="bibr29-0194599812439670">29</xref></sup> In Koreans, IVS7-2A&gt;G accounts for 20% of mutant <italic>SLC26A4</italic> alleles and is the second most prevalent genetic variant after c.2168A&gt;G.<sup><xref ref-type="bibr" rid="bibr12-0194599812439670">12</xref></sup> In Japanese individuals, IVS7-2A&gt;G has a low incidence of approximately 3%, and c.2168A&gt;G is the leading variant.<sup><xref ref-type="bibr" rid="bibr10-0194599812439670">10</xref></sup> Apart from IVS7-2A&gt;G, the mutation spectrum of <italic>SLC26A4</italic> is broad, with prevalent mutations extending from exon 3 to exon 19, indicting the necessity of sequencing all coding sequences of <italic>SLC26A4</italic>.</p>
<p>Aside from the mutation spectrum, the <italic>SLC26A4</italic> allele mutation genotype (biallele, monoallele, or zero allele) did not relate to hearing levels in our results. As PTA and ASSR adopt different hearing indexes, we analyzed hearing results separately. This would reduce the group numbers but increase the comparability and reliability to reflect a genotype-phenotype relationship. Regarding the degree of deafness, 93.0% of the patients with <italic>SLC26A4</italic> mutations suffered from severe to profound deafness involving the whole frequency, especially at high frequencies, corresponding to the pathophysiology of inner ear malformations. Further genotype and phenotype analysis of <italic>SLC26A4</italic> mutations is recommended.</p>
<p>It is important to note that this research has some limitations. First, testing of a relatively larger cohort is necessary to testify the veracity of our results. Additional screening of the <italic>SLC26A4</italic> promoter region may reveal additional information, as our strategy of direct sequencing of the coding sequences and adjacent intronic sequences may have missed some mutations. Furthermore, we could not perform haplotype analysis in patients with no or a single <italic>SLC26A4</italic> mutant allele because of the lack of informative family subjects. The wide <italic>SLC26A4</italic> mutation spectrums in these 15 patients also limited haplotype analysis.</p>
</sec>
<sec id="section8-0194599812439670" sec-type="conclusions">
<title>Conclusion</title>
<p>This study indicates that <italic>SLC26A4</italic> accounts for 74.4% of inner ear malformations in our cohort, whereas <italic>FOXI1, KCNJ10</italic>, and <italic>GJB2</italic> mutations are not common, indicating that other genes or external factors may possibly contribute to this multibranch abnormality.</p>
</sec>
<sec id="section9-0194599812439670">
<title>Author Contributions</title>
<p><bold>Kaitian Chen</bold>, study designation, patients’ data collection, experiment, and writing; <bold>Xianren Wang</bold>, designed and analyzed data and writing; <bold>Liang Sun</bold>, patients’ data collection, experiment, data analysis, and revising the article; <bold>Hongyan Jiang</bold>, whole experiment coordination, designation, and revising the article.</p>
</sec>
<sec id="section10-0194599812439670">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> National Basic Research Program of China (2011CB504502), National Natural Science Fund of China (30973306), and Key Nature Fund of Guangdong Province (8251008901000016).</p>
</sec>
</body>
<back>
<ack>
<p>We thank all participants in this study for their cooperation.</p>
</ack>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812439670">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Usami</surname><given-names>S</given-names></name>
<name><surname>Abe</surname><given-names>S</given-names></name>
<name><surname>Weston</surname><given-names>MD</given-names></name>
<name><surname>Shinkawa</surname><given-names>H</given-names></name>
<name><surname>Van Camp</surname><given-names>G</given-names></name>
<name><surname>Kimberling</surname><given-names>WJ</given-names></name>
</person-group>. <article-title>Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutation</article-title>. <source>Hum Genet</source>. <year>1999</year>;<volume>104</volume>(<issue>2</issue>):<fpage>188</fpage>-<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812439670">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>C</given-names></name>
<name><surname>Cucci</surname><given-names>RA</given-names></name>
<name><surname>Prasad</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Pendred syndrome, DFNB4, and PDS/SLC26A4: identification of eight novel mutations and possible genotype-phenotype correlations</article-title>. <source>Hum Mutat</source>. <year>2001</year>;<volume>17</volume>(<issue>5</issue>):<fpage>403</fpage>-<lpage>411</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812439670">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wangemann</surname><given-names>P</given-names></name>
<name><surname>Nakaya</surname><given-names>K</given-names></name>
<name><surname>Wu</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Loss of cochlear HCO3- secretion causes deafness via endolymphatic acidification and inhibition of Ca<sup>2+</sup> reabsorption in a Pendred syndrome mouse model</article-title>. <source>Am J Physiol Renal Physiol</source>. <year>2007</year>;<volume>292</volume>(<issue>5</issue>):<fpage>F1345</fpage>-<lpage>F1353</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812439670">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dai</surname><given-names>P</given-names></name>
<name><surname>Yuan</surname><given-names>Y</given-names></name>
<name><surname>Huang</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Molecular etiology of hearing impairment in inner Mongolia: mutations in SLC26A4 gene and relevant phenotype analysis</article-title>. <source>J Transl Med</source>. <year>2008</year>;<volume>6</volume>:<fpage>74</fpage>.</citation>
</ref>
<ref id="bibr5-0194599812439670">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>QJ</given-names></name>
<name><surname>Zhao</surname><given-names>YL</given-names></name>
<name><surname>Rao</surname><given-names>SQ</given-names></name>
<etal/>
</person-group>. <article-title>A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China</article-title>. <source>Clin Genet</source>. <year>2007</year>;<volume>72</volume>(<issue>3</issue>):<fpage>245</fpage>-<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr6-0194599812439670">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pera</surname><given-names>A</given-names></name>
<name><surname>Dossena</surname><given-names>S</given-names></name>
<name><surname>Rodighiero</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>(<issue>47</issue>):<fpage>18608</fpage>-<lpage>18613</lpage>.</citation>
</ref>
<ref id="bibr7-0194599812439670">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hu</surname><given-names>H</given-names></name>
<name><surname>Wu</surname><given-names>L</given-names></name>
<name><surname>Feng</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Molecular analysis of hearing loss associated with enlarged vestibular aqueduct in the mainland Chinese: a unique SLC26A4 mutation spectrum</article-title>. <source>J Hum Genet</source>. <year>2007</year>;<volume>52</volume>(<issue>6</issue>):<fpage>492</fpage>-<lpage>497</lpage>.</citation>
</ref>
<ref id="bibr8-0194599812439670">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>Y</given-names></name>
<name><surname>You</surname><given-names>Y</given-names></name>
<name><surname>Huang</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Comprehensive molecular etiology analysis of nonsyndromic hearing impairment from typical areas in China</article-title>. <source>J Transl Med</source>. <year>2009</year>;<volume>7</volume>:<fpage>79</fpage>.</citation>
</ref>
<ref id="bibr9-0194599812439670">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dai</surname><given-names>P</given-names></name>
<name><surname>Li</surname><given-names>Q</given-names></name>
<name><surname>Huang</surname><given-names>D</given-names></name>
</person-group>, <etal/>. <article-title>SLC26A4 c. 919-2A&gt;G varies among Chinese ethnic groups as a cause of hearing loss</article-title>. <source>Genet Med</source>. <year>2008</year>;<volume>10</volume>(<issue>8</issue>):<fpage>586</fpage>-<lpage>592</lpage>.</citation>
</ref>
<ref id="bibr10-0194599812439670">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsukamoto</surname><given-names>K</given-names></name>
<name><surname>Suzuki</surname><given-names>H</given-names></name>
<name><surname>Harada</surname><given-names>D</given-names></name>
<name><surname>Namba</surname><given-names>A</given-names></name>
<name><surname>Abe</surname><given-names>S</given-names></name>
<name><surname>Usami</surname><given-names>S</given-names></name>
</person-group>. <article-title>Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese</article-title>. <source>Eur J Hum Genet</source>. <year>2003</year>;<volume>11</volume>(<issue>12</issue>):<fpage>916</fpage>-<lpage>922</lpage>.</citation>
</ref>
<ref id="bibr11-0194599812439670">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Albert</surname><given-names>S</given-names></name>
<name><surname>Blons</surname><given-names>H</given-names></name>
<name><surname>Jonard</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations</article-title>. <source>Eur J Hum Genet</source>. <year>2006</year>;<volume>14</volume>(<issue>6</issue>):<fpage>773</fpage>-<lpage>779</lpage>.</citation>
</ref>
<ref id="bibr12-0194599812439670">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>HJ</given-names></name>
<name><surname>Lee</surname><given-names>SJ</given-names></name>
<name><surname>Jin</surname><given-names>HS</given-names></name>
<etal/>
</person-group>. <article-title>Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans</article-title>. <source>Clin Genet</source>. <year>2005</year>;<volume>67</volume>(<issue>2</issue>):<fpage>160</fpage>-<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr13-0194599812439670">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>T</given-names></name>
<name><surname>Vidarsson</surname><given-names>H</given-names></name>
<name><surname>Rodrigo-Blomqvist</surname><given-names>S</given-names></name>
<name><surname>Rosengren</surname><given-names>SS</given-names></name>
<name><surname>Enerback</surname><given-names>S</given-names></name>
<name><surname>Smith</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Transcriptional control of SLC26A4 is involved in Pendred syndrome and non-syndromic enlargement of vestibular aqueduct (DFNB4)</article-title>. <source>Am J Hum Genet</source>. <year>2007</year>;<volume>80</volume>(<issue>6</issue>):<fpage>1055</fpage>-<lpage>1063</lpage>.</citation>
</ref>
<ref id="bibr14-0194599812439670">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>T</given-names></name>
<name><surname>Gurrola</surname><given-names>JG</given-names><suffix>II</suffix></name>
<name><surname>Wu</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Mutations of KCNJ10 together with mutations of SLC26A4 cause digenic non-syndromic hearing loss associated with enlarged vestibular aqueduct syndrome</article-title>. <source>Am J Hum Genet</source>. <year>2009</year>;<volume>84</volume>(<issue>5</issue>):<fpage>651</fpage>-<lpage>657</lpage>.</citation>
</ref>
<ref id="bibr15-0194599812439670">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hulander</surname><given-names>M</given-names></name>
<name><surname>Kiernan</surname><given-names>AE</given-names></name>
<name><surname>Blomqvist</surname><given-names>SR</given-names></name>
<etal/>
</person-group>. <article-title>Lack of pendrin expression leads to deafness and expansion of the endolymphatic compartment in inner ears of Foxi1 null mutant mice</article-title>. <source>Development</source>. <year>2003</year>;<volume>130</volume>(<issue>9</issue>):<fpage>2013</fpage>-<lpage>2025</lpage>.</citation>
</ref>
<ref id="bibr16-0194599812439670">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>CC</given-names></name>
<name><surname>Lu</surname><given-names>YC</given-names></name>
<name><surname>Chen</surname><given-names>PJ</given-names></name>
<etal/>
</person-group>. <article-title>Phenotypic analyses and mutation screening of the SLC26A4 and FOXI1 genes in 101 Taiwanese families with bilateral nonsyndromic enlarged vestibular aqueduct (DFNB4) or Pendred syndrome</article-title>. <source>Audiol Neurootol</source>. <year>2010</year>;<volume>15</volume>(<issue>1</issue>):<fpage>57</fpage>-<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr17-0194599812439670">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Propst</surname><given-names>EJ</given-names></name>
<name><surname>Blaser</surname><given-names>S</given-names></name>
<name><surname>Stockley</surname><given-names>TL</given-names></name>
<name><surname>Harrison</surname><given-names>RV</given-names></name>
<name><surname>Gordon</surname><given-names>KA</given-names></name>
<name><surname>Papsin</surname><given-names>BC</given-names></name>
</person-group>. <article-title>Temporal bone imaging in GJB2 deafness</article-title>. <source>Laryngoscope</source>. <year>2006</year>;<volume>116</volume>(<issue>12</issue>):<fpage>2178</fpage>-<lpage>2186</lpage>.</citation>
</ref>
<ref id="bibr18-0194599812439670">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kenna</surname><given-names>MA</given-names></name>
<name><surname>Rehm</surname><given-names>HL</given-names></name>
<name><surname>Frangulov</surname><given-names>A</given-names></name>
<name><surname>Feldman</surname><given-names>HA</given-names></name>
<name><surname>Robson</surname><given-names>CD</given-names></name>
</person-group>. <article-title>Temporal bone abnormalities in children with GJB2 mutations</article-title>. <source>Laryngoscope</source>. <year>2011</year>;<volume>121</volume>(<issue>3</issue>):<fpage>630</fpage>-<lpage>635</lpage>.</citation>
</ref>
<ref id="bibr19-0194599812439670">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>KH</given-names></name>
<name><surname>Larson</surname><given-names>DA</given-names></name>
<name><surname>Shott</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Audiologic and temporal bone imaging findings in patients with sensorineural hearing loss and GJB2 mutations</article-title>. <source>Laryngoscope</source>. <year>2009</year>;<volume>119</volume>(<issue>3</issue>):<fpage>554</fpage>-<lpage>558</lpage>.</citation>
</ref>
<ref id="bibr20-0194599812439670">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sennaroglu</surname><given-names>L</given-names></name>
<name><surname>Saatci</surname><given-names>I.</given-names></name>
</person-group> <article-title>A new classification for cochleovestibular malformations</article-title>. <source>Laryngoscope</source>. <year>2002</year>;<volume>112</volume>(<issue>12</issue>):<fpage>2230</fpage>-<lpage>2241</lpage>.</citation>
</ref>
<ref id="bibr21-0194599812439670">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dai</surname><given-names>P</given-names></name>
<name><surname>Yu</surname><given-names>F</given-names></name>
<name><surname>Han</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>The prevalence of the 235delC GJB2 mutation in a Chinese deaf population</article-title>. <source>Genet Med</source>. <year>2007</year>;<volume>9</volume>(<issue>5</issue>):<fpage>283</fpage>-<lpage>289</lpage>.</citation>
</ref>
<ref id="bibr22-0194599812439670">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferraris</surname><given-names>A</given-names></name>
<name><surname>Rappaport</surname><given-names>E</given-names></name>
<name><surname>Santacroce</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Pyrosequencing for detection of mutations in the Connexin 26 (GJB2) and Mitochondrial 12S RNA (MTRNR1) genes associated with hereditary hearing loss</article-title>. <source>Hum Mutat</source>. <year>2002</year>;<volume>20</volume>(<issue>4</issue>):<fpage>312</fpage>-<lpage>320</lpage>.</citation>
</ref>
<ref id="bibr23-0194599812439670">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>HJ</given-names></name>
<name><surname>Shuakat</surname><given-names>S</given-names></name>
<name><surname>Liu</surname><given-names>XZ</given-names></name>
<etal/>
</person-group>. <article-title>Origins and frequencies of SLC26A4 (PDS) mutations in East and South Asians: global implications for the epidemiology of deafness</article-title>. <source>J Med Genet</source>. <year>2003</year>;<volume>40</volume>(<issue>4</issue>):<fpage>242</fpage>-<lpage>248</lpage>.</citation>
</ref>
<ref id="bibr24-0194599812439670">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simões-Teixeira</surname><given-names>H</given-names></name>
<name><surname>Matos</surname><given-names>TD</given-names></name>
<name><surname>Marques</surname><given-names>MC</given-names></name>
</person-group>, <etal/>. <article-title>Novel splice-site mutation c. 1615-2A&gt;G (IVS14-2A&gt;G) in the SLC26A4 gene causing Pendred syndrome in a consanguineous Portuguese family</article-title>. <source>Am J Med Genet A</source>. <year>2011</year>;<volume>155</volume>(<issue>4</issue>):<fpage>924</fpage>-<lpage>927</lpage>.</citation>
</ref>
<ref id="bibr25-0194599812439670">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jonard</surname><given-names>L</given-names></name>
<name><surname>Niasme-Grare</surname><given-names>M</given-names></name>
<name><surname>Bonnet</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Screening of SLC26A4, FOXI1 and KCNJ10 genes in unilateral hearing impairment with ipsilateral enlarged vestibular aqueduct</article-title>. <source>Int J Pediatr Otorhinolaryngol</source>. <year>2010</year>;<volume>74</volume>(<issue>9</issue>):<fpage>1049</fpage>-<lpage>1053</lpage>.</citation>
</ref>
<ref id="bibr26-0194599812439670">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pollak</surname><given-names>A</given-names></name>
<name><surname>Skórka</surname><given-names>A</given-names></name>
<name><surname>Mueller-Malesińska</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance</article-title>. <source>Am J Med Genet A</source>. <year>2007</year>;<volume>143</volume>(<issue>21</issue>):<fpage>2534</fpage>-<lpage>2543</lpage>.</citation>
</ref>
<ref id="bibr27-0194599812439670">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pryor</surname><given-names>SP</given-names></name>
<name><surname>Demmler</surname><given-names>GJ</given-names></name>
<name><surname>Madeo</surname><given-names>AC</given-names></name>
<etal/>
</person-group>. <article-title>Investigation of the role of congenital cytomegalovirus infection in the etiology of enlarged vestibular aqueducts</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2005</year>;<volume>131</volume>(<issue>5</issue>):<fpage>388</fpage>-<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr28-0194599812439670">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>J</given-names></name>
<name><surname>Wu</surname><given-names>LQ</given-names></name>
<name><surname>Feng</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Mutational screening of the SLC26A4 gene in patients with nonsyndromic hearing loss by denaturing high-performance liquid chromatography [in Chinese]</article-title>. <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source>. <year>2009</year>;<volume>26</volume>(<issue>1</issue>):<fpage>21</fpage>-<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr29-0194599812439670">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>JJ</given-names></name>
<name><surname>Tsai</surname><given-names>CC</given-names></name>
<name><surname>Hsu</surname><given-names>HM</given-names></name>
<name><surname>Shiao</surname><given-names>JY</given-names></name>
<name><surname>Su</surname><given-names>CC</given-names></name>
<name><surname>Li</surname><given-names>SY</given-names></name>
</person-group>. <article-title>Hearing loss associated with enlarged vestibular aqueduct and Mondini dysplasia is caused by splice-site mutation in the PDS gene</article-title>. <source>Hear Res</source>. <year>2005</year>;<volume>199</volume>(<issue>1-2</issue>):<fpage>22</fpage>-<lpage>30</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>